Blueshift Asset Management’s Medifast MED Stock Holding History

Blueshift Asset Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-9,638	Closed	-$1.86M	–	1083
2021 Q3	$1.86M	Buy	9,638 +2,478	+35%	+$609K	0.1%	257
2021 Q2	$2.03M	Sell	7,160 -3,855	-35%	-$1.04M	0.11%	219
2021 Q1	$2.33M	Buy	11,015 +6,579	+148%	+$1.57M	0.24%	103
2020 Q4	$871K	Buy	+4,436	New	+$784K	0.1%	297
2019 Q4	–	Sell	-20,037	Closed	-$2.08M	–	939
2019 Q3	$2.08M	Buy	20,037 +5,061	+34%	+$544K	0.32%	74
2019 Q2	$1.92M	Buy	14,976 +8,489	+131%	+$1.18M	0.25%	111
2019 Q1	$827K	Buy	+6,487	New	+$823K	0.12%	284

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Blueshift Asset Management's MED Position: Q4 2021 in Review

Blueshift Asset Management sold out of Medifast (MED) in Q4 2021, closing a stake of 9,638 shares — an estimated $1.86M sold.

Blueshift Asset Management first reported a position in MED in Q1 2019 and held it in 7 quarters. The position peaked at $2.33M in Q1 2021. 297 funds tracked by Wall St. Rank hold MED as of Q4 2021.

Blueshift Asset Management reported no remaining Medifast position as of Q4 2021 after selling out during the quarter.
Blueshift Asset Management sold 9,638 Medifast shares in Q4 2021, an estimated $1.86M.
Blueshift Asset Management first reported a position in Medifast in Q1 2019 and held it in 7 quarters.
Blueshift Asset Management's Medifast position peaked at $2.33M in Q1 2021.
297 funds tracked by Wall St. Rank held Medifast as of Q4 2021.

Based on Blueshift Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.